Unknown

Dataset Information

Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.


ABSTRACT:

Objectives

Enrolment of subjects to clinical trials investigating novel drugs for infectious diseases is an ongoing challenge. In this study, we evaluate factors associated with non-enrolment in treatment trials for invasive candidiasis.

Methods

We conducted a retrospective review of pre-screening logs of patients that were assessed for enrolment in the three clinical trials ACTIVE (NCT00413218), APX001-201 (NCT03604705) and ReSTORE (NCT03667690), investigating novel drugs for invasive candidiasis between September 2007 and August 2021 to identify reasons for study ineligibility.

Results

Two hundred and fifty-six patients with invasive candidiasis were identified for potential study participation with n = 154 for the ACTIVE trial, n = 89 for APX001-201 and n = 13 for

SUBMITTER: Sprute R 

PROVIDER: S-EPMC9704424 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature